1 Apr 2026
Impact of SLCO1B1 and ABCB1 variants on statin efficacy and toxicity in a Tunisian populationPublisher siteDrug Metabolism and Disposition, Lipoproteins and Cardiovascular Health
UniversitiesAsma Omezzine
Active, last published 2026
In diabetes, cardiovascular risks, and lipoproteins
Asma
Omezzine
Scholar“Research focused on Diabetes, Cardiovascular Risks, and Lipoproteins and adjacent fields.”
Hôpital Sahloul
Claim Your Profile21
H-index
1.4k
Citations
Asma has not officially claimed their profile. If you are Asma, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
sma Omezzine is a researcher working on Diabetes, Cardiovascular Risks, and Lipoproteins. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Asma's work has been cited 1,368 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Diabetes, Cardiovascular Risks, and Lipoproteins×16Lipoproteins and Cardiovascular Health×12Folate and B Vitamins Research×10Adipokines, Inflammation, and Metabolic Diseases×10Adipose Tissue and Metabolism×10
04 · Where I am
Affiliations
Affiliation on published researchHôpital SahloulDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 worksExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Asma?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you